Dongwha Pharm's 'Pancol'

Acetaminophen for After Vaccination Is Also Available Here View original image

[Asia Economy Reporter Seo So-jeong] Dongwha Pharm's 'Pancol' is a comprehensive cold medicine effective for early cold treatment, launched in 1968 and sold for over 50 years.


Dongwha Pharm completed a lineup reflecting various age groups by releasing two types of children's cold medicine 'Pancol I' in 2018, following 'Pancol S' sold at pharmacies and 'Pancol A' sold at convenience stores.


Among the various Pancol series, Pancol A can be purchased at convenience stores and is characterized by its liquid form, which allows for rapid absorption into the body.


It contains 300mg of acetaminophen, which has antipyretic and analgesic effects, making it effective in relieving most cold symptoms such as chills, fever, headache, joint pain, muscle pain, runny nose, nasal congestion, sneezing, cough, sore throat, and phlegm.


Recently, health authorities have recommended taking antipyretic analgesics containing acetaminophen for symptoms such as fever and muscle pain caused by COVID-19 vaccination, increasing interest in medicines containing this ingredient.



Over-the-counter medicines containing acetaminophen range from single formulations to combination formulations like Pancol A, and appropriate treatment can be taken after consulting a doctor or pharmacist depending on the symptoms.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing